While the candidate achieved pharmacokinetic objectives, the program was discontinued due to a single case of potential liver injury among over 1,400 trial participants
Smith, 2026 journals.sagepub.com To view or add a comment, sign in Depression has traditionally been framed as a disorder of neurotransmitters
Bristol Myers Squibbs KarXTs is being tested to treatAlzheimers psychosis and cognitive symptoms., Cognito Therapeutics SPECTRIS headset uses flickering lights and sounds to stimulate the brain in early Alzheimers
If stomach discomfort is a symptom, though, avoid this supplement or add it to your diet very slowly
Recent clinical trials, published in September 2025 in The New England Journal of Medicine , show that high-dose oral semaglutide tablets can deliver weight loss results that begin to approach what we see with injections